GB2568928B - Neuroprotective composition, preparation process thereof and medical uses thereof - Google Patents

Neuroprotective composition, preparation process thereof and medical uses thereof Download PDF

Info

Publication number
GB2568928B
GB2568928B GB1720018.9A GB201720018A GB2568928B GB 2568928 B GB2568928 B GB 2568928B GB 201720018 A GB201720018 A GB 201720018A GB 2568928 B GB2568928 B GB 2568928B
Authority
GB
United Kingdom
Prior art keywords
preparation process
medical uses
neuroprotective composition
neuroprotective
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1720018.9A
Other versions
GB2568928A (en
GB2568928A8 (en
GB201720018D0 (en
Inventor
Chen Te-Fu
Wang Kuo-Chuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Young Cell Biomedical Tech Inc
Original Assignee
Young Cell Biomedical Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Young Cell Biomedical Tech Inc filed Critical Young Cell Biomedical Tech Inc
Priority to GB1720018.9A priority Critical patent/GB2568928B/en
Publication of GB201720018D0 publication Critical patent/GB201720018D0/en
Priority to TW107142430A priority patent/TWI694148B/en
Priority to CN201811465488.XA priority patent/CN109966317B/en
Publication of GB2568928A publication Critical patent/GB2568928A/en
Publication of GB2568928A8 publication Critical patent/GB2568928A8/en
Application granted granted Critical
Publication of GB2568928B publication Critical patent/GB2568928B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
GB1720018.9A 2017-12-01 2017-12-01 Neuroprotective composition, preparation process thereof and medical uses thereof Active GB2568928B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB1720018.9A GB2568928B (en) 2017-12-01 2017-12-01 Neuroprotective composition, preparation process thereof and medical uses thereof
TW107142430A TWI694148B (en) 2017-12-01 2018-11-28 Neuroprotective composition, preparation process thereof and medical uses thereof
CN201811465488.XA CN109966317B (en) 2017-12-01 2018-12-03 Neuroprotective composition, process for its preparation and its medical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1720018.9A GB2568928B (en) 2017-12-01 2017-12-01 Neuroprotective composition, preparation process thereof and medical uses thereof

Publications (4)

Publication Number Publication Date
GB201720018D0 GB201720018D0 (en) 2018-01-17
GB2568928A GB2568928A (en) 2019-06-05
GB2568928A8 GB2568928A8 (en) 2019-12-11
GB2568928B true GB2568928B (en) 2023-03-08

Family

ID=60950200

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1720018.9A Active GB2568928B (en) 2017-12-01 2017-12-01 Neuroprotective composition, preparation process thereof and medical uses thereof

Country Status (3)

Country Link
CN (1) CN109966317B (en)
GB (1) GB2568928B (en)
TW (1) TWI694148B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110179827A (en) * 2019-06-27 2019-08-30 北京三有利和泽生物科技有限公司 The application of Odontogenic cysts mescenchymal stem cell
CN111467373A (en) * 2020-04-24 2020-07-31 西安交通大学 Dental pulp stem cell exosome preparation, preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008060788A2 (en) * 2006-10-11 2008-05-22 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
EP2554175A1 (en) * 2010-03-26 2013-02-06 National University Corporation Nagoya University Composition for treatment of damaged part
WO2015028900A1 (en) * 2013-08-29 2015-03-05 Stempeutics Research Pvt. Ltd. Stromal cells derived conditioned medium, method of obtaining said conditioned medium compositions, formulations and applications thereof
CN106967679A (en) * 2017-03-23 2017-07-21 北京恒峰铭成生物科技有限公司 A kind of preparation method and applications of anti-senility liquid
WO2017139795A1 (en) * 2016-02-12 2017-08-17 Cell Care Therapeutics Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2753833A1 (en) * 2008-02-28 2009-09-03 Henry Ford Health System Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries
KR101675123B1 (en) * 2014-06-27 2016-11-14 연세대학교 산학협력단 A Composition for Treating Ischemic Diseases or Neuroinflammatory Diseases Comprising PSA-NCAM-positive Neural Precursor Cells as Active Ingredient
JP2017533917A (en) * 2014-11-05 2017-11-16 ティッシュテック，インク． Compositions and methods for promoting nerve growth and regeneration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008060788A2 (en) * 2006-10-11 2008-05-22 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
EP2554175A1 (en) * 2010-03-26 2013-02-06 National University Corporation Nagoya University Composition for treatment of damaged part
WO2015028900A1 (en) * 2013-08-29 2015-03-05 Stempeutics Research Pvt. Ltd. Stromal cells derived conditioned medium, method of obtaining said conditioned medium compositions, formulations and applications thereof
WO2017139795A1 (en) * 2016-02-12 2017-08-17 Cell Care Therapeutics Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same
CN106967679A (en) * 2017-03-23 2017-07-21 北京恒峰铭成生物科技有限公司 A kind of preparation method and applications of anti-senility liquid

Also Published As

Publication number Publication date
GB2568928A (en) 2019-06-05
TWI694148B (en) 2020-05-21
GB2568928A8 (en) 2019-12-11
CN109966317B (en) 2023-02-03
TW201925463A (en) 2019-07-01
CN109966317A (en) 2019-07-05
GB201720018D0 (en) 2018-01-17

Similar Documents

Publication Publication Date Title
HUE054964T2 (en) Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
IL275055A (en) Triabody, preparation method and use thereof
SI3453707T1 (en) Benzazepine derivative, preparation method, pharmaceutical composition and use thereof
ZA201900470B (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
EP3722497A4 (en) Fabric treatment composition
PL3590924T3 (en) Novel isoindoline derivative, and pharmaceutical composition and application thereof
DK3657954T3 (en) Non-hydrogenated fat composition, use and process
EP3450460C0 (en) Multi-specific binding conjugate, related pharmaceutical compositions and use
EP3281527A4 (en) Antimicrobial traditional chinese medicine composition, and preparation method and use thereof
IL252397A0 (en) Pharmaceutical composition, preparation and uses thereof
IL290114A (en) Pharmaceutical composition, preparation and uses thereof
ZA201806888B (en) Molecular sieve, its preparation and application thereof
HK1254379A1 (en) Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use
PL3638278T3 (en) Neuroprotective compositions and their use
LT3229843T (en) Pharmaceutical composition, preparation and uses thereof
GB2568928B (en) Neuroprotective composition, preparation process thereof and medical uses thereof
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
IL262929B1 (en) Composition, and application and pharmaceutical preparation thereof
IL274785A (en) Combination products containing dicycloplatin, preparation and use thereof
GB2579240B (en) New processes, compositions and medical uses
ZA201906907B (en) Analytical and therapeutic methods and compositions, and uses thereof
ZA201908109B (en) Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
HK1250496B (en) Powder cosmetic composition, uses and process for the preparation thereof
ZA201904328B (en) Composition, application thereof and treatment method
PL3389858T3 (en) Catalyst composition, its preparation and process using such composition

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20221027 AND 20221102